Journal Article Summary
The article investigates the effects of the Levonorgestrel-releasing intrauterine device (LNG-IUD) on quality of life in women experiencing heavy menstrual bleeding, particularly in relation to different endometrial pathology patterns. Heavy menstrual bleeding is a prevalent issue that can significantly impact a woman's physical and emotional well-being. Understanding how the LNG-IUD affects quality of life based on underlying endometrial conditions is crucial for improving treatment options and patient outcomes.
In this retrospective study, researchers analyzed data from 143 women aged 28 to 54 who had heavy menstrual bleeding and underwent endometrial sampling before receiving the LNG-IUD. The participants were divided into two groups based on their endometrial pathology: normal cycle patterns and hormonal imbalance patterns. The study found that, regardless of the type of endometrial pathology, there was a significant improvement in quality of life scores after the LNG-IUD was inserted, as measured by various assessment tools, including the Menorrhagia Multiattribute Scale and the SF-36 Health Survey.
However, the study has some limitations, including its retrospective design, which may lead to inaccuracies in recalling past symptoms. Additionally, while the assessment tools used are reliable, the Turkish version of the Menorrhagia Multiattribute Scale has not been formally validated. Patients should discuss these findings with their healthcare providers, especially if they are considering LNG-IUD treatment for heavy menstrual bleeding, to ensure it aligns with their individual health needs and conditions.
Medical Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Kolcu Selma Atiye, Kara Ebru, Yıldız Elif, Çetin Arzu. Levonorgestrel-releasing intrauterine device treatment in heavy menstrual bleeding: Correlation with endometrial pathology and quality of life. PLOS One 2025. DOI: 10.1371/journal.pone.0338480. PMID: 41379816. PMCID: PMC12697963.
Featured Pill Pals Product
OPill (O-Pill) Norgestrel Tablets 0.075 mg Daily Oral Contraceptive (Birth Control) --- Perrigo --- Over The Counter
OPill (O-Pill) Norgestrel Tablets 0.075 mg Daily Oral Contraceptive (Birth Control) — Perrigo — Over The Counter is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. This is an Over The Counter Product, so no prescription is required.However, your prescriber can still write for it as a prescription, if desired.
